Cargando…
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
Little is known about the immune environment of ovarian clear cell carcinoma (OCCC) and its impact on various ethnic backgrounds. The aim of this OCCC immune‐related gene expression signatures (irGES) study was to address the interaction between tumour and immune environment of ethnically‐diverse As...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539643/ https://www.ncbi.nlm.nih.gov/pubmed/34322886 http://dx.doi.org/10.1002/path.5769 |
_version_ | 1784803533789331456 |
---|---|
author | Heong, Valerie Tan, Tuan Z Miwa, Maiko Ye, Jieru Lim, Diana Herrington, C Simon Iida, Yasushi Yano, Mitsutake Yasuda, Masanori Ngoi, Natalie YL Wong, SB Justin Okamoto, Aikou Gourley, Charlie Hasegawa, Kosei Tan, David SP Huang, Ruby YJ |
author_facet | Heong, Valerie Tan, Tuan Z Miwa, Maiko Ye, Jieru Lim, Diana Herrington, C Simon Iida, Yasushi Yano, Mitsutake Yasuda, Masanori Ngoi, Natalie YL Wong, SB Justin Okamoto, Aikou Gourley, Charlie Hasegawa, Kosei Tan, David SP Huang, Ruby YJ |
author_sort | Heong, Valerie |
collection | PubMed |
description | Little is known about the immune environment of ovarian clear cell carcinoma (OCCC) and its impact on various ethnic backgrounds. The aim of this OCCC immune‐related gene expression signatures (irGES) study was to address the interaction between tumour and immune environment of ethnically‐diverse Asian and Caucasian populations and to identify relevant molecular subsets of biological and clinical importance. Our study included 264 women from three different countries (Singapore, Japan, and the UK) and identified four novel immune subtypes (PD1‐high, CTLA4‐high, antigen‐presentation, and pro‐angiogenic subtype) with differentially expressed pathways, and gene ontologies using the NanoString nCounter PanCancer Immune Profiling Panel. The PD1‐high and CTLA4‐high subtypes demonstrated significantly higher PD1, PDL1, and CTLA4 expression, and were associated with poorer clinical outcomes. Mismatch repair (MMR) protein expression, assessed by immunohistochemistry, revealed that about 5% of OCCCs had deficient MMR expression. The prevalence was similar across the three countries and appeared to cluster in the CTLA4‐high subtype. Our results suggest that OCCC from women of Asian and Caucasian descent shares significant clinical and molecular similarities. To our knowledge, our study is the first study to include both Asian and Caucasian women with OCCC and helps to shine light on the impact of ethnic differences on the immune microenvironment of OCCC. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. |
format | Online Article Text |
id | pubmed-9539643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-95396432022-11-16 A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma Heong, Valerie Tan, Tuan Z Miwa, Maiko Ye, Jieru Lim, Diana Herrington, C Simon Iida, Yasushi Yano, Mitsutake Yasuda, Masanori Ngoi, Natalie YL Wong, SB Justin Okamoto, Aikou Gourley, Charlie Hasegawa, Kosei Tan, David SP Huang, Ruby YJ J Pathol Original Papers Little is known about the immune environment of ovarian clear cell carcinoma (OCCC) and its impact on various ethnic backgrounds. The aim of this OCCC immune‐related gene expression signatures (irGES) study was to address the interaction between tumour and immune environment of ethnically‐diverse Asian and Caucasian populations and to identify relevant molecular subsets of biological and clinical importance. Our study included 264 women from three different countries (Singapore, Japan, and the UK) and identified four novel immune subtypes (PD1‐high, CTLA4‐high, antigen‐presentation, and pro‐angiogenic subtype) with differentially expressed pathways, and gene ontologies using the NanoString nCounter PanCancer Immune Profiling Panel. The PD1‐high and CTLA4‐high subtypes demonstrated significantly higher PD1, PDL1, and CTLA4 expression, and were associated with poorer clinical outcomes. Mismatch repair (MMR) protein expression, assessed by immunohistochemistry, revealed that about 5% of OCCCs had deficient MMR expression. The prevalence was similar across the three countries and appeared to cluster in the CTLA4‐high subtype. Our results suggest that OCCC from women of Asian and Caucasian descent shares significant clinical and molecular similarities. To our knowledge, our study is the first study to include both Asian and Caucasian women with OCCC and helps to shine light on the impact of ethnic differences on the immune microenvironment of OCCC. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2021-09-01 2021-11 /pmc/articles/PMC9539643/ /pubmed/34322886 http://dx.doi.org/10.1002/path.5769 Text en © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Papers Heong, Valerie Tan, Tuan Z Miwa, Maiko Ye, Jieru Lim, Diana Herrington, C Simon Iida, Yasushi Yano, Mitsutake Yasuda, Masanori Ngoi, Natalie YL Wong, SB Justin Okamoto, Aikou Gourley, Charlie Hasegawa, Kosei Tan, David SP Huang, Ruby YJ A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title | A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title_full | A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title_fullStr | A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title_full_unstemmed | A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title_short | A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
title_sort | multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma |
topic | Original Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539643/ https://www.ncbi.nlm.nih.gov/pubmed/34322886 http://dx.doi.org/10.1002/path.5769 |
work_keys_str_mv | AT heongvalerie amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT tantuanz amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT miwamaiko amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yejieru amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT limdiana amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT herringtoncsimon amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT iidayasushi amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yanomitsutake amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yasudamasanori amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT ngoinatalieyl amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT wongsbjustin amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT okamotoaikou amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT gourleycharlie amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT hasegawakosei amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT tandavidsp amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT huangrubyyj amultiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT heongvalerie multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT tantuanz multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT miwamaiko multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yejieru multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT limdiana multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT herringtoncsimon multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT iidayasushi multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yanomitsutake multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT yasudamasanori multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT ngoinatalieyl multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT wongsbjustin multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT okamotoaikou multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT gourleycharlie multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT hasegawakosei multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT tandavidsp multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma AT huangrubyyj multiethnicanalysisofimmunerelatedgeneexpressionsignaturesinpatientswithovarianclearcellcarcinoma |